+987.9%
MRNA vs NWSA
+18.2%
+969.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NWSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.7% | +9.4% | +11.7% |
| 7D | +20.6% | +4.3% | +16.4% | +18.9% |
| 30D | +27.1% | +5.6% | +21.6% | +24.3% |
| 3M | +353.4% | +7.3% | +346.1% | +338.2% |
| 6M | +446.3% | +18.8% | +427.4% | +393.6% |
| YTD | +776.2% | +17.9% | +758.3% | +695.7% |
| 1Y | +987.9% | +19.3% | +968.6% | +877.5% |
| All | +987.9% | +18.2% | +969.7% | +877.5% |
Cumulative growth
Daily Returns
Daily percentage return beside NWSA.
Daily Out/Under-Performance
Portfolio return minus NWSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NWSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NWSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling